Rob Halford on sobriety, health scares, the ‘remarkable' Glenn Tipton, and being Grammy-nominated 50 years into Judas Priest's career
Some old-school metalheads may blast the Grammy Awards for supposedly having no rock cred, but that absolutely isn't the case ...
Game Rant22d
Judas Should Come Out of the Gate Swinging
Judas needs to reveal a release date to meet the "before March 2025" launch goal. The next Judas reveal should showcase a wealth of story and gameplay details. Whenever Judas does finally show its ...
Game Rant27d
A 2025 Release Date for Judas Seems More Unlikely by the Day
Judas may not launch in 2025 as expected, with a delay to 2026 possible due to lack of an official release date. Judas could stealth drop this year to avoid overhype and generate buzz, but timing ...
Metal Injection6d
GOJIRA Wins A GRAMMY For "Mea Culpa (Ah! Ça Ira!)" In The Best Metal Performance Category
Gojira beat out Judas Priest, Knocked Loose, Metallica, and Spiritbox in the category (all of whom also deserved it, frankly). This year's nominations for the Best Metal Performance category at the ...
CBS News9d
FDA OK's painkiller designed to end opioids' addiction and overdose risk
Washington — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
The Boston Globe8d
At $31 a day, is Vertex’s new non-addictive painkiller worth the price?
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at least as effective and costs only 50 cents a pill? They will if the ...
People9d
FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
Vertex Pharmaceuticals A new painkiller has been approved for the first time in 25 years — and there's no risk of addiction, experts say. On Thursday, Jan. 30, The U.S. Food and Drug ...
Yahoo Finance9d
The FDA approved a new non-opioid painkiller. Its maker's stock is rising
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators. Journavx, or suzetrigine ...
Spectrum News NY19d
FDA approves painkiller designed to eliminate risk of addiction associated with opioids
WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
WTVD6d
Doctor, advocate weigh in on new non-opioid pain killer Journavx
The FDA reports this painkiller does not carry the risk of addiction or overdose associated with opioids. "We're very excited to see these drugs coming in. We need more and more options that are ...
Yahoo4d
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex Pharmaceuticals. The drug, which is called suzetrigine and will be sold under ...